Anthera Pharmaceuticals, Inc. (ANTH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2017 | -1.65 USD | 84.1% |
| 2016 | -10.38 USD | -32.4% |
| 2015 | -7.84 USD | 29.56% |
| 2014 | -11.13 USD | 23.24% |
| 2013 | -14.50 USD | 77.95% |
| 2012 | -65.77 USD | 59.67% |
| 2011 | -163.06 USD | -44.43% |
| 2010 | -112.90 USD | 78.12% |
| 2009 | -516.03 USD | 32.57% |
| 2008 | -765.33 USD | 29.56% |
| 2007 | -1086.46 USD | -25.17% |
| 2006 | -868.00 USD | -1507.41% |
| 2005 | -54.00 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 Q1 | -0.20 USD | 73.68% |
| 2017 Q2 | 0.92 USD | 153.18% |
| 2017 Q3 | -0.43 USD | -146.74% |
| 2017 Q4 | -0.76 USD | -76.74% |
| 2017 FY | - USD | 84.1% |
| 2017 Q1 | -1.73 USD | 29.39% |
| 2016 FY | - USD | -32.4% |
| 2016 Q1 | -2.34 USD | -59.18% |
| 2016 Q2 | -2.79 USD | -19.23% |
| 2016 Q3 | -3.16 USD | -13.26% |
| 2016 Q4 | -2.45 USD | 22.47% |
| 2015 Q3 | -2.31 USD | -16.08% |
| 2015 Q2 | -1.99 USD | 10.36% |
| 2015 FY | - USD | 29.56% |
| 2015 Q1 | -2.22 USD | 14.62% |
| 2015 Q4 | -1.47 USD | 36.36% |
| 2014 Q1 | -3.15 USD | 17.54% |
| 2014 FY | - USD | 23.24% |
| 2014 Q3 | -2.46 USD | 8.89% |
| 2014 Q2 | -2.70 USD | 14.29% |
| 2014 Q4 | -2.60 USD | -5.69% |
| 2013 Q2 | -3.48 USD | 11.0% |
| 2013 FY | - USD | 77.95% |
| 2013 Q3 | -2.42 USD | 30.46% |
| 2013 Q4 | -3.82 USD | -57.85% |
| 2013 Q1 | -3.91 USD | 45.77% |
| 2012 Q1 | -32.64 USD | 28.36% |
| 2012 FY | - USD | 59.67% |
| 2012 Q4 | -7.21 USD | 34.45% |
| 2012 Q3 | -11.00 USD | 59.87% |
| 2012 Q2 | -27.41 USD | 16.02% |
| 2011 Q4 | -45.56 USD | -18.92% |
| 2011 Q1 | -36.12 USD | -42.54% |
| 2011 Q2 | -42.49 USD | -17.64% |
| 2011 Q3 | -38.31 USD | 9.84% |
| 2011 FY | - USD | -44.43% |
| 2010 Q1 | -53.25 USD | 12.16% |
| 2010 FY | - USD | 78.12% |
| 2010 Q4 | -25.34 USD | -9.08% |
| 2010 Q3 | -23.23 USD | -1.66% |
| 2010 Q2 | -22.85 USD | 57.09% |
| 2009 FY | - USD | 32.57% |
| 2009 Q4 | -60.62 USD | 60.03% |
| 2009 Q3 | -151.68 USD | -6.28% |
| 2009 Q2 | -142.72 USD | 13.36% |
| 2009 Q1 | -164.72 USD | 1.59% |
| 2008 FY | - USD | 29.56% |
| 2008 Q4 | -167.38 USD | 27.91% |
| 2008 Q3 | -232.19 USD | 0.0% |
| 2007 FY | - USD | -25.17% |
| 2006 FY | - USD | -1507.41% |
| 2005 FY | - USD | 0.0% |